The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
Enzyme structure and mechanism
Fersht, A. (1977) · Medical Entomology and Zoology · Cited by 2,875
Enzyme structure and mechanism
Elmore, D. T. (1978) · Endeavour · doi:10.1016/0160-9327(78)90081-9 · Cited by 2,710
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. M., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,498
Transforming gene product of Rous sarcoma virus phosphorylates tyrosine
Hunter, T., & Sefton, B. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1311 · Cited by 2,332
Protein Tyrosine Phosphatases in the Human Genome
Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., & Mustelin, T. (2004) · Cell · doi:10.1016/j.cell.2004.05.018 · Cited by 1,886
Knighton, D. R., Zheng, J., Ten Eyck, L. F., Ashford, V. A., Xuong, N.-H., Taylor, S. S., & Sowadski, J. M. (1991) · Science · doi:10.1126/science.1862342 · Cited by 1,759
The Conformational Plasticity of Protein Kinases
Huse, M., & Kuriyan, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00741-9 · Cited by 1,752
ERK1/2 MAP kinases: Structure, function, and regulation
Roskoski, R. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.04.005 · Cited by 1,650
Self-citationThree-dimensional structure of the tyrosine kinase c-Src
Xu, W., Harrison, S. C., & Eck, M. J. (1997) · Nature · doi:10.1038/385595a0 · Cited by 1,418
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
Self-citationDNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA
STEHELIN, D., VARMUS, H. E., BISHOP, J. M., & VOGT, P. K. (1976) · Nature · doi:10.1038/260170a0 · Cited by 1,321 · cited 1×
“/ Pharmacological Research 94 (2015) 9–25 11”
Lombardo, L. J., Lee, F. Y., Chen, P., Norris, D., Barrish, J. C., Behnia, K., Castaneda, S., Cornelius, L. A. M., Das, J., Doweyko, A. M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049486a · Cited by 1,297
Regulation, substrates and functions of src
Brown, M. T., & Cooper, J. A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00003-0 · Cited by 1,172
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
Cortes, J. E., Kim, D.-W., Pinilla-Ibarz, J., le Coutre, P., Paquette, R., Chuah, C., Nicolini, F. E., Apperley, J. F., Khoury, H. J., Talpaz, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306494 · Cited by 1,142
Rational design of inhibitors that bind to inactive kinase conformations
Liu, Y., & Gray, N. S. (2006) · Nature Chemical Biology · doi:10.1038/nchembio799 · Cited by 1,094
A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS
Rous, P. (1911) · Journal of Experimental Medicine · doi:10.1084/jem.13.4.397 · Cited by 1,051
Protein kinases: evolution of dynamic regulatory proteins
Taylor, S. S., & Kornev, A. P. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.09.006 · Cited by 945
Crystal Structures of c-Src Reveal Features of Its Autoinhibitory Mechanism
Xu, W., Doshi, A., Lei, M., Eck, M. J., & Harrison, S. C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80356-1 · Cited by 870
Kornev, A. P., Haste, N. M., Taylor, S. S., & Ten Eyck, L. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607656103 · Cited by 762
Kinetic and Catalytic Mechanisms of Protein Kinases
Adams, J. A. (2001) · Chemical Reviews · doi:10.1021/cr000230w · Cited by 627
Kmiecik, T. E., & Shalloway, D. (1987) · Cell · doi:10.1016/0092-8674(87)90756-2 · Cited by 623
Src protein–tyrosine kinase structure and regulation
Roskoski, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.171 · Cited by 596
Self-citationZheng, J., Knighton, D. R., Ten Eyck, L. F., Karlsson, R., Xuong, N., Taylor, S. S., & Sowadski, J. M. (1993) · Biochemistry · doi:10.1021/bi00060a005 · Cited by 589
Src kinase regulation by phosphorylation and dephosphorylation
Roskoski, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.012 · Cited by 577
Self-citationPolyproline-II Helix in Proteins: Structure and Function
Adzhubei, A. A., Sternberg, M. J. E., & Makarov, A. A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.018 · Cited by 547
Tyr 527 Is Phosphorylated in pp60 c- src : Implications for Regulation
Cooper, J. A., Gould, K. L., Cartwright, C. A., & Hunter, T. (1986) · Science · doi:10.1126/science.2420005 · Cited by 540
Targeting the PDGF signaling pathway in tumor treatment
Heldin, C.-H. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-97 · Cited by 540
Fibroblast growth factors and their receptors in cancer
Wesche, J., Haglund, K., & Haugsten, E. M. (2011) · Biochemical Journal · doi:10.1042/bj20101603 · Cited by 534
An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates
Eckhart, W., Hutchinson, M. A., & Hunter, T. (1979) · Cell · doi:10.1016/0092-8674(79)90205-8 · Cited by 525
A Myristoyl/Phosphotyrosine Switch Regulates c-Abl
Hantschel, O., Nagar, B., Guettler, S., Kretzschmar, J., Dorey, K., Kuriyan, J., & Superti-Furga, G. (2003) · Cell · doi:10.1016/s0092-8674(03)00191-0 · Cited by 480
Shah, K., Liu, Y., Deirmengian, C., & Shokat, K. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3565 · Cited by 417
Activation of tyrosine kinases by mutation of the gatekeeper threonine
Azam, M., Seeliger, M. A., Gray, N. S., Kuriyan, J., & Daley, G. Q. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1486 · Cited by 411
Dynamics of cAMP-Dependent Protein Kinase
Johnson, D. A., Akamine, P., Radzio-Andzelm, E., Madhusudan, & Taylor, S. S. (2001) · Chemical Reviews · doi:10.1021/cr000226k · Cited by 393
Cook, P. F., Neville, M. E., Vrana, K. E., Hartl, F. T., & Roskoski, R. (1982) · Biochemistry · doi:10.1021/bi00266a011 · Cited by 379
Self-citationKinase Drug Discovery – What’s Next in the Field?
Cohen, P., & Alessi, D. R. (2013) · ACS Chemical Biology · doi:10.1021/cb300610s · Cited by 377
Recognition and specificity in protein tyrosine kinase-mediated signalling
Songyang, Z., & Cantley, L. C. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89103-3 · Cited by 370
Huang, W.-S., Metcalf, C. A., Sundaramoorthi, R., Wang, Y., Zou, D., Thomas, R. M., Zhu, X., Cai, L., Wen, D., Liu, S., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100395q · Cited by 369
Hennequin, L. F., Allen, J., Breed, J., Curwen, J., Fennell, M., Green, T. P., Lambert-van der Brempt, C., Morgentin, R., Norman, R. A., Olivier, A., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060434q · Cited by 364
Czernilofsky, A. P., Levinson, A. D., Varmus, H. E., Bishop, J. M., Tischer, E., & Goodman, H. M. (1980) · Nature · doi:10.1038/287198a0 · Cited by 321
Targeting Src family kinases in anti-cancer therapies: turning promise into triumph
Zhang, S., & Yu, D. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.11.002 · Cited by 319
Hennequin, L. F., Stokes, E. S. E., Thomas, A. P., Johnstone, C., Plé, P. A., Ogilvie, D. J., Dukes, M., Wedge, S. R., Kendrew, J., & Curwen, J. O. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm011022e · Cited by 311
Regulation of the Src Family Kinases by Csk
Okada, M. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.5141 · Cited by 309
EphrinB Phosphorylation and Reverse Signaling
Palmer, A., Zimmer, M., Erdmann, K. S., Eulenburg, V., Porthin, A., Heumann, R., Deutsch, U., & Klein, R. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00488-4 · Cited by 305
A Protein Tyrosine Kinase Involved in Regulation of pp60c-src function
Okada, M., & Nakagawa, H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30019-5 · Cited by 301
MEK1/2 dual-specificity protein kinases: Structure and regulation
Roskoski, R. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.145 · Cited by 276
Self-citationCASK Functions as a Mg2+-independent neurexin kinase
Mukherjee, K., Sharma, M., Urlaub, H., Bourenkov, G. P., Jahn, R., Südhof, T. C., & Wahl, M. C. (2008) · Cell · doi:10.1016/j.cell.2008.02.036 · Cited by 271
Williams, J. C., Weijland, A., Gonfloni, S., Thompson, A., Courtneidge, S. A., Superti-Furga, G., & Wierenga, R. K. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1426 · Cited by 250
Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors
Araujo, J., & Logothetis, C. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.02.015 · Cited by 244
A phosphotyrosine displacement mechanism for activation of Src by PTPα
Zheng, X.-M., Resnick, R. J., & Shalloway, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.964 · Cited by 234
Evolution of the eukaryotic protein kinases as dynamic molecular switches
Taylor, S. S., Keshwani, M. M., Steichen, J. M., & Kornev, A. P. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0054 · Cited by 233
ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.001 · Cited by 218
Self-citationBarker, W. C., & Dayhoff, M. O. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.9.2836 · Cited by 216
Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress
Cui, J. J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401427c · Cited by 209
Deciphering the Structural Basis of Eukaryotic Protein Kinase Regulation
Meharena, H. S., Chang, P., Keshwani, M. M., Oruganty, K., Nene, A. K., Kannan, N., Taylor, S. S., & Kornev, A. P. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001680 · Cited by 208
Taylor, S. S., Radzio‐Andzelm, E., & Hunter, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.13.7557015 · Cited by 188
Variation on an Src-like Theme
Harrison, S. C. (2003) · Cell · doi:10.1016/s0092-8674(03)00196-x · Cited by 186
A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity
Levinson, N. M., & Boxer, S. G. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1404 · Cited by 171
Hybrid Compound Design To Overcome the Gatekeeper T338M Mutation in cSrc
Getlik, M., Grütter, C., Simard, J. R., Klüter, S., Rabiller, M., Rode, H. B., Robubi, A., & Rauh, D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9002928 · Cited by 159
Current status of SRC inhibitors in solid tumor malignancies
Puls, L. N., Eadens, M., & Messersmith, W. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0408 · Cited by 158
Peng, Y.-H., Shiao, H., Tu, C., Liu, P.-M., Hsu, J. T.-A., Amancha, P. K., Wu, J., Coumar, M. S., Chen, C.-H., Wang, S.-Y., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400072p · Cited by 156
A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src
Liu, Y., Shah, K., Yang, F., Witucki, L. A., & Shokat, K. M. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00099-6 · Cited by 156
Protein prenylation: a pivotal posttranslational process
Roskoski, R. J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00323-1 · Cited by 151
Self-citationEqually Potent Inhibition of c-Src and Abl by Compounds that Recognize Inactive Kinase Conformations
Seeliger, M. A., Ranjitkar, P., Kasap, C., Shan, Y., Shaw, D. E., Shah, N. P., Kuriyan, J., & Maly, D. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3953 · Cited by 148
Steinberg, R. A., Cauthron, R. D., Symcox, M. M., & Shuntoh, H. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.4.2332 · Cited by 144
Zoller, M. J., & Taylor, S. S. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86899-0 · Cited by 140
The language of SH2 domain interactions defines phosphotyrosine‐mediated signal transduction
Liu, B. A., Engelmann, B. W., & Nash, P. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.054 · Cited by 132
Kaplan, J. M., Mardon, G., Bishop, J. M., & VARMUS, H. E. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.6.2435 · Cited by 131
Corrections to the nucleotide sequence of the src gene of Rous sarcoma virus
Czernilofsky, A. P., Levinson, A. D., VARMUS, H. E., Bishop, J. M., Tischer, E., & Goodman, H. M. (1983) · Nature · doi:10.1038/301736b0 · Cited by 124
Targeting the insulin-like growth factor-1 receptor in human cancer
Arcaro, A. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00030 · Cited by 122
Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation
Sun, G., Sharma, A., & Budde, R. J. A. (1998) · Oncogene · doi:10.1038/sj.onc.1202076 · Cited by 99
DAUD, A. I., Krishnamurthi, S., Saleh, M. N., Gitlitz, B. J., Borad, M. J., Gold, P. J., Chiorean, E. G., Springett, G. M., Abbas, R., Agarwal, S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2378 · Cited by 92
Locking the Active Conformation of c-Src Kinase through the Phosphorylation of the Activation Loop
Meng, Y., & Roux, B. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.10.001 · Cited by 89
Phosphoryl Transfer by Protein Kinase A Is Captured in a Crystal Lattice
Bastidas, A. C., Deal, M. S., Steichen, J. M., Guo, Y., Wu, J., & Taylor, S. S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja312237q · Cited by 83
Participation of ADP Dissociation in the Rate-Determining Step in cAMP-Dependent Protein Kinase
Zhou, J., & Adams, J. A. (1997) · Biochemistry · doi:10.1021/bi971438n · Cited by 83
Brignola, P. S., Lackey, K. E., Kadwell, S. H., Hoffman, C. R., Horne, E., Carter, H. L., Stuart, J. D., Blackburn, K., Moyer, M. B., Alligood, K. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105907200 · Cited by 77
Parast, C. V., Mroczkowski, B., Pinko, C., et al. (1998) · Biochemistry · doi:10.1021/bi981291f · Cited by 75
7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as Dual Inhibitors of Src and Abl Kinases
Boschelli, D. H., Wang, Y. D., Johnson, S., Wu, B., Ye, F., Sosa, A. C. B., Golas, J. M., & Boschelli, F. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0499458 · Cited by 72
Jacobsen, D. M., Bao, Z., O’Brien, P., Brooks, C. L., & Young, M. A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304419t · Cited by 70
Association of Csk-homologous Kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in Breast Cancer Cells
Zrihan‐Licht, S., Lim, J., Keydar, I., Sliwkowski, M. X., Groopman, J. E., & Avraham, H. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1856 · Cited by 68
IGF-IR Targeted Therapy: Past, Present and Future
Janssen, J. A. M. J. L., & Varewijck, A. J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00224 · Cited by 67
Adams, J. A., & Taylor, S. S. (1993) · Protein Science · doi:10.1002/pro.5560021217 · Cited by 61
Chong, Y., Mulhern, T. D., Zhu, H., Fujita, D. J., Bjorge, J. D., Tantiongco, J.-P., Sotirellis, N., Lio, D. S. S., Scholz, G. M., & Cheng, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309865200 · Cited by 59
A Myristoyl/Phosphoserine Switch Controls cAMP-Dependent Protein Kinase Association to Membranes
Gaffarogullari, E. C., Masterson, L. R., Metcalfe, E. E., Traaseth, N. J., Balatri, E., Musa, M., Mullen, D. G., Distefano, M. D., & Veglia, G. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.06.034 · Cited by 56
Lovitt, B., VanderPorten, E. C., Sheng, Z., Zhu, H., Drummond, J., & Liu, Y. (2010) · Biochemistry · doi:10.1021/bi901726c · Cited by 52
Sun, G., Ramdas, L., Wang, W., Vinci, J., McMurray, J., & Budde, R. J. A. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2627 · Cited by 49
Structure and specificity of the SH2 domain
Waksman, G., & Kuriyan, J. (2004) · Cell · doi:10.1016/s0092-8674(04)00043-1 · Cited by 38
Laurie, S. A., Goss, G. D., Shepherd, F. A., Reaume, M. N., Nicholas, G. A., Philip, L., Wang, L. E., Schwock, J., Hirsh, V., Oza, A. M., et al. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.08.001 · Cited by 35
Moy, B., Neven, P., Lebrun, F., Bellet, M., Xu, B., Sarosiek, T., Chow, L. W. C., Goss, P. E., Zacharchuk, C., Leip, E. P., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0021 · Cited by 35
The discovery and development of vandetanib for the treatment of thyroid cancer
Sim, M. W., & Cohen, M. S. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.866942 · Cited by 34
Ahn, J. S., Lee, K. H., Sun, J., Park, K., Kang, E., Cho, E. K., Lee, K. H., Kim, S., Lee, G., Kang, J., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.08.027 · Cited by 33
Activation Loop Phosphorylation Modulates Bruton’s Tyrosine Kinase (Btk) Kinase Domain Activity
Lin, L., Czerwiński, R., Kelleher, K. S., Siegel, M. M., Wu, P. W., Kriz, R., AULABAUGH, A. E., & Stahl, M. (2009) · Biochemistry · doi:10.1021/bi8019756 · Cited by 24
Role of divalent metals in the kinetic mechanism of insulin receptor tyrosine kinase
Vicario, P. P., Saperstein, R., & Bennun, A. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90349-9 · Cited by 20
Metal-Free cAMP-Dependent Protein Kinase Can Catalyze Phosphoryl Transfer
Gerlits, O. O., Das, A., Keshwani, M. M., Taylor, S. S., Waltman, M. J., Langan, P. A., Heller, W. T., & Kovalevsky, A. Y. (2014) · Biochemistry · doi:10.1021/bi5000965 · Cited by 17
Liu, M., Girma, E., Glicksman, M. A., & Stein, R. L. (2010) · Biochemistry · doi:10.1021/bi100244j · Cited by 15
Src kinase inhibitors induce apoptosis and mediate cell cycle arrest in lymphoma cells
Nowak, D., Boehrer, S., Hochmuth, S., Trepohl, B., Hofmann, W., Hoelzer, D. F., Hofmann, W., Mitrou, P. S., Ruthardt, M., & Chow, K. U. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3281721ff6 · Cited by 14
Hekmat-Nejad, M., Cai, T. Z., & Swinney, D. C. (2010) · Biochemistry · doi:10.1021/bi901609m · Cited by 7
Cited by
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.021 · Cited by 886
Self-citationProperties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
Roskoski, R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104609 · Cited by 559
Self-citationProperties of FDA-approved small molecule protein kinase inhibitors
Roskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.006 · Cited by 554
Self-citationA historical overview of protein kinases and their targeted small molecule inhibitors
Roskoski, R. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.010 · Cited by 526
Self-citationRoskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.014 · Cited by 487
Self-citation
Metadata
- Authors
- Roskoski, R.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 94
- Pages
- 9-25
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2054466658
- Cited by
- 607
- References
- 98
- FWCI
- 16.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.